A CASE OF LUNG ADENOCARCINOMA HARBORING BOTH A KRAS MUTATION AND AN EML4-ALK FUSION GENE WITH RESPONSE TO CRIZOTINIB

被引：0
|
作者：
Menefee, Michael E. [1 ]
D'Amico, Thomas A. [2 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Duke Univ, Med Ctr, Durham, NC 27706 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
KRAS; Crizotinib; NSCLC; EML4-ALK;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.24-033
引用
收藏
页码：S1315 / S1316
页数：2
相关论文
共 50 条
  • [31] The Prevalence of the EML4-ALK Fusion Gene in Cytology Specimens from Patients with Lung Adenocarcinoma
    Heriyanto, Didik S.
    Trisnawati, Ika
    Kumara, Evan G.
    Laiman, Vincent
    Yuliani, Fara S.
    Sumpono, Auliya S. B.
    Cempaka, Rita
    Marcellus
    Budiono, Eko
    PULMONARY MEDICINE, 2020, 2020
  • [32] The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
    Bilgin, Burak
    Sendur, Mehmet Ali Nahit
    Yucel, Sebnem
    Hizal, Mutlu
    Guner, Gurkan
    Akyurek, Nalan
    Erol, Cihan
    Akinci, Muhammed Bulent
    Dede, Didem Sener
    Yalcin, Bulent
    Kilickap, Sadettin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2637 - 2643
  • [33] The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
    Burak Bilgin
    Mehmet Ali Nahit Şendur
    Şebnem Yücel
    Mutlu Hizal
    Gürkan Güner
    Nalan Akyürek
    Cihan Erol
    Muhammed Bülent Akıncı
    Didem Şener Dede
    Bülent Yalçın
    Sadettin Kılıçkap
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2637 - 2643
  • [34] Synchronal pulmonary sarcomatoid carcinoma and lung adenocarcinoma EML4-ALK fusion: A case report
    Wang, Mingting
    Gong, Yifan
    Cheng, Yun
    Yang, Lei
    Wang, Wenhui
    Lei, Xiaolin
    ONCOLOGY LETTERS, 2022, 24 (04)
  • [35] A Case of EML4-ALK Fusion Lung Adenocarcinoma in an 18-year-old Patient
    Chang, A.
    De, A.
    Kass, A. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [36] Concomitance of a novel RMDN2-ALK fusion and an EML4-ALK fusion in a lung adenocarcinoma
    Jiang, Liqun
    Chen, Suping
    Stinnett, Victoria
    Haley, Lisa
    Morsberger, Laura
    Shane, Alison
    Hardy, Melanie
    Smith, Kirstin
    Gocke, Christopher D.
    Lin, Ming-Tseh
    Zhou, Ying S.
    CANCER GENETICS, 2021, 258 : 18 - 22
  • [37] Ineffectiveness of Crizotinib on Brain Metastases in Two Cases of Lung Adenocarcinoma with EML4-ALK Rearrangement
    Maillet, Denis
    Martel-Lafay, Isabelle
    Arpin, Dominique
    Perol, Maurice
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (04) : E30 - E31
  • [38] Signet ring cell adenocarcinoma of the lung with an EML4-ALK fusion gene mimicking mucinous (colloid) adenocarcinoma: A case report
    Ohba, Taro
    Sugio, Kenji
    Kometani, Takuro
    Yamaguchi, Masafumi
    Hamatake, Motoharu
    Nosaki, Kaname
    Takeoka, Hiroaki
    Kitajima, Hiromoto
    Hirai, Fumihiko
    Seto, Takashi
    Taguchi, Kenichi
    Nishiyama, Kenichi
    Shida, Yoshitaka
    Ichinose, Yukito
    LUNG CANCER, 2011, 73 (03) : 375 - 378
  • [39] Lung adenocarcinoma harboring complex EML4-ALK fusion and BRAF V600E co-mutation responded to alectinib
    Guo, Weihong
    Liang, Jianping
    Zhang, Dandan
    Huang, Xikun
    Lv, Yanhua
    MEDICINE, 2022, 101 (40) : E30913
  • [40] PARTIAL RESPONSE TO FIRST-LINE GEFITINIB FOR ADVANCED PULMONARY ADENOCARCINOMA HARBORING BOTH SYNCHRONOUS EGFR MUTATION AND EML4-ALK FUSION: REPORT OF TWO CASES
    Yang, Jinji
    Zhang, Xu-Chao
    Su, Jian
    Xu, Chong-Rui
    Huang, Yi-Sheng
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1242 - S1242
12345